Dr Reddys Laboratories
BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
News on Dr Reddys Laboratories
HSBC Equity Fund: Review
4.14 pm | 28 Feb 2014 | Source: Moneycontrol.com
This scheme is the flagship fund of the mutual fund house. The scheme had the highest exposure to banks at the end of July 2012 with 21 per cent of th...
Dr Reddy's launches Sumatriptan Injection USP
9.36 am | 26 Feb 2014 | Source: Moneycontrol.com
Dr Reddy's Laboratories launched the drug in US market which is going to show some amount of incremental momentum for the US market. They have launche...
Dipan Mehta positive on pharma stocks
4.08 pm | 21 Feb 2014 | Source: CNBC-TV18
Dipan Mehta, Member of BSE & NSE is positive on pharma companies with a medium to long term perspective....
Go long in Dr Reddys Laboratories: Amit Gupta
10.53 am | 19 Feb 2014 | Source: CNBC-TV18
According to Amit Gupta, head- derivatives at ICICI Direct, one may go long in Dr Reddys Laboratories at around Rs 2600-2650 and expects it to test Rs...
Quick Links for Dr Reddys Laboratories
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.